iBio, Inc. (IBIO) vs XBiotech Inc. (XBIT)
A side-by-side comparison of iBio, Inc. and XBiotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IBIO
iBio, Inc.
$1.05HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
XBIT
XBiotech Inc.
$2.16HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — IBIO vs XBIT
growth of $100 · dividends reinvested · last 10yIBIO -100.0% (-54.1%/yr)XBIT -81.5% (-15.5%/yr)XBIT compounded faster over this window
Log scale — wide-divergence pair
IBIO XBIT
IBIO vs XBIT: by the numbers
- •IBIO is the larger company ($67M vs $66M market cap).
- •Both run net losses; XBIT's is the smaller (0.00% vs -33044.00% net margin).
Metrics side by side
Valuation
| Metric | IBIO | XBIT |
|---|---|---|
| P/S ratio | 672.01 | N/A |
| P/B ratio | 0.78 | 0.51 |
Profitability
| Metric | IBIO | XBIT |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -35141.00% | 0.00% |
| Net margin | -33044.00% | 0.00% |
| ROE | -38.55% | -35.13% |
| ROIC | -40.22% | -37.01% |
Growth (annualized)
| Metric | IBIO | XBIT |
|---|---|---|
| Revenue CAGR (5Y) | -46.91% | N/A |
| Total return CAGR (5Y) | -70.43% | -29.36% |
Frequently asked
- How have IBIO and XBIT total returns compared?
- Over the past 10 years, IBIO delivered -54.11% and XBIT delivered -15.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.